Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
33.96
-0.54 (-1.57%)
At close: Jun 17, 2026
Market Cap264.59M -34.4%
Revenue (ttm)474.73M -5.8%
Net Income22.02M -16.0%
EPS2.92 -17.3%
Shares Out 7.79M
PE Ratio11.63
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,781
Open34.00
Previous Close34.50
Day's Range33.90 - 34.50
52-Week Range29.00 - 59.78
Beta0.76
Analystsn/a
Price Targetn/a
Earnings DateMay 27, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporate... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements